phosphoric acid, potassium salt

Cauloside F (9CI, ACI)

Germacrone (6CI, 7CI)

Motavizumab

Veltuzumab

β-D-Fructose (9CI)

Tefibazumab

Pagibaximab

Certolizumab

(1aR,2E,4aR,6S,7S,7aR,8R,10R,11aS)-1,1a,4a,5,6,7,7a,8,9,10,11,11a-Dodecahydro-4a,7,8,10-tetrahydroxy-1,1,3,6-tetramethyl-9-methylene-4H-cyclopenta[a]cyclopropa[f]cycloundecen-4-one (ACI)

Poly[(methylimino)(1-oxo-1,2-ethanediyl)], α-[4-[(2R)-2,3-bis[(1-oxotetradecyl)oxy]propoxy]-1,4-dioxobutyl]-ω-(ethylamino)- (ACI)

Tadocizumab

Aselizumab

Siplizumab

Immunoglobulin G1 [236-phenylalanine,237-glutamic acid,333-serine,de-449-lysine], anti-(human claudin-1) (human-Rattus norvegicus monoclonal ALE.F02 γ1-chain), disulfide with human-Rattus norvegicus monoclonal ALE.F02 κ-chain, dimer (ACI)

Immunoglobulin G4 [224-proline,234-glutamic acid,427-leucine,433-serine], anti-(human complement C1s) (human-Mus musculus monoclonal SAR445088 γ4-chain), disulfide with human-Mus musculus monoclonal SAR445088 κ-chain, dimer (ACI)

Immunoglobulin G4 [228-proline,234-alanine,235-alanine,de-447-lysine], anti-(human endothelin ETA receptor) (human-Mus musculus monoclonal GMA301 γ4-chain), disulfide with human-Mus musculus monoclonal GMA301 κ-chain, dimer (ACI)

Immunoglobulin G1 [233-alanine,234-alanine,327-arginine,de-446-lysine], anti-(human type 1 transferrin receptor) (human-Mus musculus clone AV05 γ1-chain), disulfide with human-Mus musculus clone AV05 κ-chain, dimer (ACI)

Immunoglobulin G4 [225-proline], anti-(human interleukin 17A) (human-Mus musculus monoclonal JS005 γ4-chain), disulfide with human-Mus musculus monoclonal JS005 κ-chain, dimer (ACI)

Immunoglobulin G4 [228-proline,de-447-lysine], anti-(human transforming growth factor β1 large latent complex) (human monoclonal SRK-181 γ4-chain), disulfide with human monoclonal SRK-181 κ-chain, dimer (ACI)